Augustina Isioma Ikusemoro: Quality Indicators for Red Blood Cells in Transfusion Medicine
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Quality Indicators for Red Blood Cells in Transfusion Medicine
Ensuring the quality of Red Blood Cell (RBC) components is critical for safe and effective transfusion therapy.
Both Packed RBCs and Apheresis RBCs are monitored through strict quality indicators aligned with standards from the AABB.
Key parameters include:
Hemoglobin Content
Ensures adequate oxygen-carrying capacity.
- Packed RBCs: ≥50 g/unit
- Apheresis RBCs: ≥80 g/unit
Hematocrit
Reflects red cell concentration and transfusion efficiency.
- Typical range: 50–70%
Hemolysis at Expiry
Indicator of membrane integrity during storage.
Acceptable limit: ≤1%
Unit Volume Consistency
Standard volumes under Unit Volume Consistency:
- Packed RBCs: 250–350 mL
- Apheresis RBCs: 300–400mL
Ensures standardized dosing and predictable clinical outcomes.
Residual Leukocyte Count (Leukoreduction)
- Target: <5 × 10⁶ leukocytes/unit
Reduces febrile reactions, alloimmunization, and CMV transmission risk.
Sterility
All RBC units must remain free of microbial contamination.
Maintaining these quality indicators strengthens blood safety, regulatory compliance, and patient outcomes in modern transfusion medicine.
Ultimately, every RBC unit transfused represents a carefully controlled biological therapy designed to deliver life-saving oxygen to patients who need it most.”
Other posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
Aug 22, 2026, 17:27Masudah Paleker: Suboptimal Warfarin Control in South Africa
-
Aug 22, 2026, 17:26Maxime Dely: Sickle Cell Disease – Behind Every Exchange, There Is a Donor
-
Aug 22, 2026, 17:05Mostafa Elshazly: Managing Anticoagulant-Related Bleeding in Clinical Practice
-
Aug 22, 2026, 17:01Cesarovic Nikola: FDA Data Reanalysis Raises Questions About Moderna’s mFLUSIVA Risk-Benefit Profile
-
Aug 22, 2026, 16:38Andreas Linkermann: Decoding the Chain Reaction of Ferroptotic Cell Death
-
Aug 22, 2026, 16:33Nicolas Hulscher: FDA Data Reanalysis Raises Alarms Over Moderna’s MFLUSIVA
-
Aug 22, 2026, 16:19Moti Haim: Transforming AF Care in the Elderly
-
Aug 22, 2026, 16:12Hussam Hammoud: A Slap Is Not “Just a Slap” When the Patient Has Hemophilia
-
Aug 22, 2026, 15:53Howard Smith: Publix’s GreenWise Organic Frozen Berries Have E. coli Contamination